The bocx posted: “If the company is in fact raising money and that is why the proxy is required, then voting against it would make the financing impossible, which would result in (a) Smithline taking over and (b) the company being disbanded.”
My comment: The SEC form PRE 14A filed last Friday states that BioCurex still has over 37 million remaining authorized shares that have not been issued or reserved for any other purpose. By any measure, that is a huge number of shares that are immediately available for meeting the needs mentioned in the filing. Yet, according to the filing, BioCurex management believes an additional 175 million authorized shares are now necessary. What is going on here? Is this a last-ditch attempt to save BioCurex? kag